Business Context and Reporting Period
This Form 8-K Current Report was filed by Prothena Corporation plc on April 28, 2023, covering events occurring on April 25, 2023. The company is incorporated in Ireland and its ordinary shares trade on the Nasdaq Global Select Market under the symbol PRTA.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes rather than financial performance.
Material Changes
The primary material change reported is the departure of a director:
- Resignation: Dr. Sanjiv K. Patel notified the Company of his decision to resign from the Board of Directors and the Compensation Committee.
- Effective Date: The resignation is effective as of July 1, 2023.
- Transition: Dr. Patel will continue to serve in both capacities until the effective date.
- Reason: The resignation is not due to any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the standard disclosure regarding the director's resignation.
Key Facts for Investor Verification
- Confirm the exact date of Dr. Patel's departure (July 1, 2023) and his continued service until that date.
- Verify if the Board has initiated a search for a replacement director to fill the vacancy.
- Check for any subsequent filings regarding the appointment of a new Compensation Committee member.